Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies

Nicola Bizzaro, Francesca Pregnolato, Martin A M Van Boekel, Danilo Villalta, Renato Tozzoli, Elio Tonutti, Antonio Antico, Maria Orietta Borghi, Allan Wiik, Pier Luigi Meroni

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: A lyophilised reference serum from one patient with rheumatoid arthritis (RA) diluted with serum samples from healthy subjects was evaluated as a possible first international standard for anticitrullinated peptide antibodies (ACPAs). Methods: The authors used 12 commercial ELISAs for ACPA detection in the reference serum and for testing the linearity of the assays by studying twofold serial dilutions. To test the effectiveness of the standardisation, sera from 20 RA patients with variable antibody concentrations were analysed, and the relative concentrations were calculated using both the kit's own curve and the six dilutions of the reference serum as a calibration curve. Fifty sera from normal healthy subjects were used to calculate cut-off values for the reference serum using each commercial kit. Results: The calibration curve obtained for each of the 12 methods using the reference sample dilutions as calibrator allowed harmonisation of the ACPA concentration of the 20 RA serum samples, significantly reducing the dispersion of the values. The mean coefficient of variation (CV) was reduced from 76.4% to 27.9% (p=0.018) and from 85.9% to 33.5% (p=0.028) for the medium/high and negative samples, respectively. Low positive sera CV was also reduced, but to a smaller degree, from 82.5% to 55.5% (p=0.043). Conclusion: This first evaluation of the behaviour of the ACPA reference serum demonstrated that it tested positive in all the assays and that it may be used as a reference standard for establishing calibration curves, reducing the dispersion of antibody values and better comparing results obtained from different methods/laboratories.

Original languageEnglish
Pages (from-to)1388-1392
Number of pages5
JournalAnnals of the Rheumatic Diseases
Volume71
Issue number8
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Peptides
Antibodies
Serum
Dilution
Calibration
Assays
Rheumatoid Arthritis
Healthy Volunteers
Standardization
Testing
Reference Values
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Allergy

Cite this

Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies. / Bizzaro, Nicola; Pregnolato, Francesca; Van Boekel, Martin A M; Villalta, Danilo; Tozzoli, Renato; Tonutti, Elio; Antico, Antonio; Borghi, Maria Orietta; Wiik, Allan; Meroni, Pier Luigi.

In: Annals of the Rheumatic Diseases, Vol. 71, No. 8, 08.2012, p. 1388-1392.

Research output: Contribution to journalArticle

Bizzaro, Nicola ; Pregnolato, Francesca ; Van Boekel, Martin A M ; Villalta, Danilo ; Tozzoli, Renato ; Tonutti, Elio ; Antico, Antonio ; Borghi, Maria Orietta ; Wiik, Allan ; Meroni, Pier Luigi. / Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies. In: Annals of the Rheumatic Diseases. 2012 ; Vol. 71, No. 8. pp. 1388-1392.
@article{f6e4de9c5ba74bea9050310555c41b7c,
title = "Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies",
abstract = "Background: A lyophilised reference serum from one patient with rheumatoid arthritis (RA) diluted with serum samples from healthy subjects was evaluated as a possible first international standard for anticitrullinated peptide antibodies (ACPAs). Methods: The authors used 12 commercial ELISAs for ACPA detection in the reference serum and for testing the linearity of the assays by studying twofold serial dilutions. To test the effectiveness of the standardisation, sera from 20 RA patients with variable antibody concentrations were analysed, and the relative concentrations were calculated using both the kit's own curve and the six dilutions of the reference serum as a calibration curve. Fifty sera from normal healthy subjects were used to calculate cut-off values for the reference serum using each commercial kit. Results: The calibration curve obtained for each of the 12 methods using the reference sample dilutions as calibrator allowed harmonisation of the ACPA concentration of the 20 RA serum samples, significantly reducing the dispersion of the values. The mean coefficient of variation (CV) was reduced from 76.4{\%} to 27.9{\%} (p=0.018) and from 85.9{\%} to 33.5{\%} (p=0.028) for the medium/high and negative samples, respectively. Low positive sera CV was also reduced, but to a smaller degree, from 82.5{\%} to 55.5{\%} (p=0.043). Conclusion: This first evaluation of the behaviour of the ACPA reference serum demonstrated that it tested positive in all the assays and that it may be used as a reference standard for establishing calibration curves, reducing the dispersion of antibody values and better comparing results obtained from different methods/laboratories.",
author = "Nicola Bizzaro and Francesca Pregnolato and {Van Boekel}, {Martin A M} and Danilo Villalta and Renato Tozzoli and Elio Tonutti and Antonio Antico and Borghi, {Maria Orietta} and Allan Wiik and Meroni, {Pier Luigi}",
year = "2012",
month = "8",
doi = "10.1136/annrheumdis-2011-200693",
language = "English",
volume = "71",
pages = "1388--1392",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies

AU - Bizzaro, Nicola

AU - Pregnolato, Francesca

AU - Van Boekel, Martin A M

AU - Villalta, Danilo

AU - Tozzoli, Renato

AU - Tonutti, Elio

AU - Antico, Antonio

AU - Borghi, Maria Orietta

AU - Wiik, Allan

AU - Meroni, Pier Luigi

PY - 2012/8

Y1 - 2012/8

N2 - Background: A lyophilised reference serum from one patient with rheumatoid arthritis (RA) diluted with serum samples from healthy subjects was evaluated as a possible first international standard for anticitrullinated peptide antibodies (ACPAs). Methods: The authors used 12 commercial ELISAs for ACPA detection in the reference serum and for testing the linearity of the assays by studying twofold serial dilutions. To test the effectiveness of the standardisation, sera from 20 RA patients with variable antibody concentrations were analysed, and the relative concentrations were calculated using both the kit's own curve and the six dilutions of the reference serum as a calibration curve. Fifty sera from normal healthy subjects were used to calculate cut-off values for the reference serum using each commercial kit. Results: The calibration curve obtained for each of the 12 methods using the reference sample dilutions as calibrator allowed harmonisation of the ACPA concentration of the 20 RA serum samples, significantly reducing the dispersion of the values. The mean coefficient of variation (CV) was reduced from 76.4% to 27.9% (p=0.018) and from 85.9% to 33.5% (p=0.028) for the medium/high and negative samples, respectively. Low positive sera CV was also reduced, but to a smaller degree, from 82.5% to 55.5% (p=0.043). Conclusion: This first evaluation of the behaviour of the ACPA reference serum demonstrated that it tested positive in all the assays and that it may be used as a reference standard for establishing calibration curves, reducing the dispersion of antibody values and better comparing results obtained from different methods/laboratories.

AB - Background: A lyophilised reference serum from one patient with rheumatoid arthritis (RA) diluted with serum samples from healthy subjects was evaluated as a possible first international standard for anticitrullinated peptide antibodies (ACPAs). Methods: The authors used 12 commercial ELISAs for ACPA detection in the reference serum and for testing the linearity of the assays by studying twofold serial dilutions. To test the effectiveness of the standardisation, sera from 20 RA patients with variable antibody concentrations were analysed, and the relative concentrations were calculated using both the kit's own curve and the six dilutions of the reference serum as a calibration curve. Fifty sera from normal healthy subjects were used to calculate cut-off values for the reference serum using each commercial kit. Results: The calibration curve obtained for each of the 12 methods using the reference sample dilutions as calibrator allowed harmonisation of the ACPA concentration of the 20 RA serum samples, significantly reducing the dispersion of the values. The mean coefficient of variation (CV) was reduced from 76.4% to 27.9% (p=0.018) and from 85.9% to 33.5% (p=0.028) for the medium/high and negative samples, respectively. Low positive sera CV was also reduced, but to a smaller degree, from 82.5% to 55.5% (p=0.043). Conclusion: This first evaluation of the behaviour of the ACPA reference serum demonstrated that it tested positive in all the assays and that it may be used as a reference standard for establishing calibration curves, reducing the dispersion of antibody values and better comparing results obtained from different methods/laboratories.

UR - http://www.scopus.com/inward/record.url?scp=84863850548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863850548&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2011-200693

DO - 10.1136/annrheumdis-2011-200693

M3 - Article

C2 - 22492784

AN - SCOPUS:84863850548

VL - 71

SP - 1388

EP - 1392

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 8

ER -